Cargando…

Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands

INTRODUCTION: New glucose-monitoring technologies have different cost–benefit profiles compared with traditional finger-prick tests, resulting in a preference-sensitive situation for patients. This study aimed to assess the relative value adults with diabetes assign to device attributes in two count...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Ian P, Whichello, Chiara L, Veldwijk, Jorien, Rutten-van Mölken, Maureen P M H, Groothuis-Oudshoorn, C G M, Vos, Rimke C, de Bekker-Grob, Esther W, de Wit, G Ardine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853131/
https://www.ncbi.nlm.nih.gov/pubmed/36649973
http://dx.doi.org/10.1136/bmjdrc-2022-003025
_version_ 1784872825749766144
author Smith, Ian P
Whichello, Chiara L
Veldwijk, Jorien
Rutten-van Mölken, Maureen P M H
Groothuis-Oudshoorn, C G M
Vos, Rimke C
de Bekker-Grob, Esther W
de Wit, G Ardine
author_facet Smith, Ian P
Whichello, Chiara L
Veldwijk, Jorien
Rutten-van Mölken, Maureen P M H
Groothuis-Oudshoorn, C G M
Vos, Rimke C
de Bekker-Grob, Esther W
de Wit, G Ardine
author_sort Smith, Ian P
collection PubMed
description INTRODUCTION: New glucose-monitoring technologies have different cost–benefit profiles compared with traditional finger-prick tests, resulting in a preference-sensitive situation for patients. This study aimed to assess the relative value adults with diabetes assign to device attributes in two countries. RESEARCH DESIGN AND METHODS: Adults with type 1 or 2 diabetes from the Netherlands (n=226) and Poland (n=261) completed an online discrete choice experiment. Respondents choose between hypothetical glucose monitors described using seven attributes: precision, effort to check, number of finger pricks required, risk of skin irritation, information provided, alarm function and out-of-pocket costs. Panel mixed logit models were used to determine attribute relative importance and to calculate expected uptake rates and willingness to pay (WTP). RESULTS: The most important attribute for both countries was monthly out-of-pocket costs. Polish respondents were more likely than Dutch respondents to choose a glucose-monitoring device over a standard finger prick and had higher WTP for a device. Dutch respondents had higher WTP for device improvements in an effort to check and reduce the number of finger pricks a device requires. CONCLUSION: Costs are the primary concern of patients in both countries when choosing a glucose monitor and would likely hamper real-world uptake. The costs-benefit profiles of such devices should be critically reviewed.
format Online
Article
Text
id pubmed-9853131
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-98531312023-01-21 Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands Smith, Ian P Whichello, Chiara L Veldwijk, Jorien Rutten-van Mölken, Maureen P M H Groothuis-Oudshoorn, C G M Vos, Rimke C de Bekker-Grob, Esther W de Wit, G Ardine BMJ Open Diabetes Res Care Emerging Technologies, Pharmacology and Therapeutics INTRODUCTION: New glucose-monitoring technologies have different cost–benefit profiles compared with traditional finger-prick tests, resulting in a preference-sensitive situation for patients. This study aimed to assess the relative value adults with diabetes assign to device attributes in two countries. RESEARCH DESIGN AND METHODS: Adults with type 1 or 2 diabetes from the Netherlands (n=226) and Poland (n=261) completed an online discrete choice experiment. Respondents choose between hypothetical glucose monitors described using seven attributes: precision, effort to check, number of finger pricks required, risk of skin irritation, information provided, alarm function and out-of-pocket costs. Panel mixed logit models were used to determine attribute relative importance and to calculate expected uptake rates and willingness to pay (WTP). RESULTS: The most important attribute for both countries was monthly out-of-pocket costs. Polish respondents were more likely than Dutch respondents to choose a glucose-monitoring device over a standard finger prick and had higher WTP for a device. Dutch respondents had higher WTP for device improvements in an effort to check and reduce the number of finger pricks a device requires. CONCLUSION: Costs are the primary concern of patients in both countries when choosing a glucose monitor and would likely hamper real-world uptake. The costs-benefit profiles of such devices should be critically reviewed. BMJ Publishing Group 2023-01-17 /pmc/articles/PMC9853131/ /pubmed/36649973 http://dx.doi.org/10.1136/bmjdrc-2022-003025 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Emerging Technologies, Pharmacology and Therapeutics
Smith, Ian P
Whichello, Chiara L
Veldwijk, Jorien
Rutten-van Mölken, Maureen P M H
Groothuis-Oudshoorn, C G M
Vos, Rimke C
de Bekker-Grob, Esther W
de Wit, G Ardine
Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
title Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
title_full Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
title_fullStr Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
title_full_unstemmed Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
title_short Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
title_sort diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in poland and the netherlands
topic Emerging Technologies, Pharmacology and Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853131/
https://www.ncbi.nlm.nih.gov/pubmed/36649973
http://dx.doi.org/10.1136/bmjdrc-2022-003025
work_keys_str_mv AT smithianp diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands
AT whichellochiaral diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands
AT veldwijkjorien diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands
AT ruttenvanmolkenmaureenpmh diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands
AT groothuisoudshoorncgm diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands
AT vosrimkec diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands
AT debekkergrobestherw diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands
AT dewitgardine diabetespatientpreferencesforglucosemonitoringtechnologiesresultsfromadiscretechoiceexperimentinpolandandthenetherlands